Liu Sai-Nan et al. [21] discovered that TIMELESS was overexpressed and associated with poorer survival in NPC, as well as conferred resistance to cisplatin-induced apoptosis and promoted the epithelial–mesenchymal transition (EMT), which could be a valuable prognostic factor and therapeutic target in NPC. The gene discussed is TIMELESS; the disease is nasopharyngeal carcinoma.